Bellevue Group’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $8.57M | Buy |
|
|||||
|
2025
Q2 | $7.06M | Buy |
|
|||||
|
2025
Q1 | $445K | Sell |
|
|||||
|
2024
Q4 | $1.34M | Sell |
|
|||||
|
2024
Q3 | $1.28M | Sell |
|
|||||
|
2024
Q2 | $2.52M | Buy |
|
|||||
|
2024
Q1 | $2.01M | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $2.72M | Buy |
|
|||||
|
2019
Q4 | $2.61M | Buy |
|
|||||
|
2019
Q3 | $1.03M | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $925K | Hold |
|
|||||
|
2018
Q3 | $1.29M | Sell |
|
|||||
|
2018
Q2 | $2.19M | Hold |
|
|||||
|
2018
Q1 | $1.54M | Sell |
|
|||||
|
2017
Q4 | $12.7M | Buy |
|
|||||
|
2017
Q3 | $10.2M | Buy |
|
|||||
|
2017
Q2 | $9.48M | Sell |
|
|||||
|
2017
Q1 | $11.8M | Buy |
|
|||||
|
2016
Q4 | $8.52M | Buy |
|
|||||
|
2016
Q3 | $8.61M | Sell |
|
|||||
|
2016
Q2 | $11.5M | Buy |
|
|||||
|
2016
Q1 | $10.4M | Buy |
|